Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NPJ precision oncology

Showing results (1-10 of 1,517) with videos related to

Pageof 152
Sort By:
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
NPJ Precision Oncology|December 9, 2022
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumorsJessica K Lee, Smruthy Sivakumar, Alexa B Schrock, et al.
NPJ Precision Oncology|March 29, 2020
ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinomaXiaofang Zhao, Wenhao Qin, Youhai Jiang, et al.
NPJ Precision Oncology|May 29, 2021
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modalityIoannis A Vathiotis, Zhi Yang, Jason Reeves, et al.
NPJ Precision Oncology|May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, David C Wilkes, Rohan Bareja, et al.
NPJ Precision Oncology|June 15, 2022
Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trialsTalha Qaiser, Ching-Yi Lee, Michel Vandenberghe, et al.
NPJ Precision Oncology|January 7, 2023
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learningR Tyler McLaughlin, Maansi Asthana, Marc Di Meo, et al.
NPJ Precision Oncology|December 15, 2022
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockadeIoannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
NPJ Precision Oncology|December 29, 2022
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancerFernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, et al.
Pageof 152

Showing results (1-10 of 1,517) with videos related to

Sort By:
Pageof 152
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
NPJ Precision Oncology|December 9, 2022
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumorsJessica K Lee, Smruthy Sivakumar, Alexa B Schrock, et al.
NPJ Precision Oncology|March 29, 2020
ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinomaXiaofang Zhao, Wenhao Qin, Youhai Jiang, et al.
NPJ Precision Oncology|May 29, 2021
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modalityIoannis A Vathiotis, Zhi Yang, Jason Reeves, et al.
NPJ Precision Oncology|May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, David C Wilkes, Rohan Bareja, et al.
NPJ Precision Oncology|June 15, 2022
Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trialsTalha Qaiser, Ching-Yi Lee, Michel Vandenberghe, et al.
NPJ Precision Oncology|January 7, 2023
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learningR Tyler McLaughlin, Maansi Asthana, Marc Di Meo, et al.
NPJ Precision Oncology|December 15, 2022
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockadeIoannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
NPJ Precision Oncology|December 29, 2022
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancerFernando Perez-Villatoro, Jaana Oikkonen, Julia Casado, et al.
Pageof 152